Changes in median TCD3, TCD4 and TCD8 counts before and after treatment Characteristics of cellular immunity Group I (n = 46) Group II (n = 14) pa TCD3 (Cell / ul) T0 2010, 5 (1268, 5 - 2975, 0) 1788, 0 (1019, 3 - 2381, 0) >0, 05 T4 1448, 5 (1007, 75 - 2275, 75) 1379, 5 (795, 3 - 1629, 5) >0, 05 |T4-T0| 455, 35 579, 79 >0, 05 pb >0, 05 <0, 05 TCD4 (Cell / ul) T0 830, 5 (552, 0 - 1407, 5) 703, 0 (494, 5 - 1085, 5) >0, 05 T4 639, 5 (481, 0 - 1103, 75) 619, 5 (378, 75 - 725, 75) >0, 05 |T4-T0| 178, 67 256, 93 >0, 05 pb >0, 05 0, 03 TCD8 (Cell / ul) T0 974, 5 (581, 5 - 1567, 25) 952, 0 (547, 0 - 1208, 25) >0, 05 T4 720, 0 (540, 5 - 1150, 5) 711, 5 (421, 75 - 882, 5) >0, 05 |T4-T0| 242, 22 213, 86 >0, 05 pb >0, 05 >0, 05 TCD4+ / TCD8+ T0 0, 96 ± 0, 28 0, 91 ± 0, 26 >0, 05 T4 0, 94 ± 0, 32 0, 80 ± 0, 28 >0, 05 |T4-T0| 0, 019 0, 111 * pa: Mann-Whitney U test, pb: Wilcoxon Signed Ranks test.